Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Renya Zeng"'
Autor:
Jianan Li, Wentao Zhang, Yi Zhao, Jixian Li, Yuanliu Nie, Alei Feng, Qiang Li, Fengge Zhou, Renya Zeng, Zhe Yang
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background With a series of clinical trials confirming the sensitivity of small cell lung cancer (SCLC) to immunotherapy, research on personalized treatment for SCLC has gained increasing attention. Currently, the most widely accepted subtyp
Externí odkaz:
https://doaj.org/article/b0505ec0cd5047b9aaa0129f142b0be4
Autor:
Yi Zhao, Yanjun Wei, Lingjia Fan, Yuanliu Nie, Jianan Li, Renya Zeng, Jixian Li, Xiang Zhan, Lingli Lei, Zhichao Kang, Jiaxin Li, Wentao Zhang, Zhe Yang
Publikováno v:
Molecular Medicine, Vol 29, Iss 1, Pp 1-18 (2023)
Abstract Background Disulfidptosis is a recently discovered programmed cell death pathway. However, the exact molecular mechanism of disulfidptosis in cutaneous melanoma remains unclear. Methods In this study, clustering analysis was performed using
Externí odkaz:
https://doaj.org/article/4445f127482c4400a5373301e0c47a0d
Autor:
Wentao Zhang, Haizeng Qu, Xiaoqing Ma, Liang Li, Yanjun Wei, Ye Wang, Renya Zeng, Yuanliu Nie, Chenggui Zhang, Ke Yin, Fengge Zhou, Zhe Yang
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundCuproptosis is a novel form of programmed cell death that differs from other types such as pyroptosis, ferroptosis, and autophagy. It is a promising new target for cancer therapy. Additionally, immune-related genes play a crucial role in ca
Externí odkaz:
https://doaj.org/article/6578b6b60eae4498997e81a0ac62975b
Autor:
Mengmeng Li, Weijia Chen, Mei Zhang, Cheng Zhang, Meng Zhang, Yu Zhang, Xiaolin Liu, Renya Zeng, Mingxue Di
Publikováno v:
International Journal of Biological Sciences
Objective: Angiogenesis is involved in multiple biological processes, including atherosclerosis (AS) and cancer. Dickkopf1 (DKK1) plays many roles in both tumors and AS and has emerged as a potential biomarker of cancer progression and prognosis. Tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ad71b9c85bee862301fc172c07a828
http://europepmc.org/articles/PMC8579465
http://europepmc.org/articles/PMC8579465
Autor:
Yongji Zeng, Ling Yin, Jiuli Zhou, Renya Zeng, Yi Xiao, Adrian R. Black, Tuo Hu, Pankaj K. Singh, Feng Yin, Surinder K. Batra, Fang Yu, Yuanhong Chen, Jixin Dong
Publikováno v:
Oncogene
Despite paclitaxel’s wide use in cancer treatment, patient response rate is still low and drug resistance is a major clinical obstacle. Through a Phos-tag-based kinome-wide screen, we identified MARK2 as a critical regulator for paclitaxel chemosen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f61d05126f3e380a89f24fe898dd00f1
https://pubmed.ncbi.nlm.nih.gov/35780183
https://pubmed.ncbi.nlm.nih.gov/35780183
Autor:
Kerry J. Rodabaugh, Ling Yin, Adam R. Karpf, Renya Zeng, Jixin Dong, Yuanhong Chen, Fang Yu, Yongji Zeng, Tian Li Wang, Amarnath Natarajan
Publikováno v:
Oncogene. 40(50)
Anti-tubulin agents, such as paclitaxel, have been used extensively for treatment of several types of cancer, including ovarian, lung, breast, and pancreatic cancers. Despite their wide use in cancer treatment, however, patient response is highly var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a6a9730ec384ddf12f9dc86eb3b74d
https://pubmed.ncbi.nlm.nih.gov/34799660
https://pubmed.ncbi.nlm.nih.gov/34799660
Autor:
Jixin Dong, Renya Zeng
Publikováno v:
Cancers
Cancers, Vol 13, Iss 318, p 318 (2021)
Cancers, Vol 13, Iss 318, p 318 (2021)
Simple Summary Although great breakthroughs have been made in cancer treatment following the development of targeted therapy and immune therapy, resistance against anti-cancer drugs remains one of the most challenging conundrums. Considerable effort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5092ef6924e0448de51eb1018cf54360
http://europepmc.org/articles/PMC7830227
http://europepmc.org/articles/PMC7830227
Autor:
Mingxue Di, Yu Zhang, Renya Zeng, Xiaolin Liu, Weijia Chen, Meng Zhang, Cheng Zhang, Mengmeng Li, Mei Zhang
Publikováno v:
International Journal of Biological Sciences; 2021, Vol. 17 Issue 15, p4122-4139, 18p
Publikováno v:
Cellular Signalling. 69:109546
Protein kinase N1 (PKN1) is a member of the protein kinase C superfamily. Aberrations of PKN1 kinase activity are involved in several human pathological processes, including cancer. We found that PKN family proteins (PKN1/2/3) are phosphorylated in r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64144d021b723d78f5f921f8bb188b07
https://doi.org/10.1016/j.cellsig.2020.109546
https://doi.org/10.1016/j.cellsig.2020.109546
Autor:
Han Wang, Xinxin Liu, Yu Zhang, Renya Zeng, Yun Zhang, Mengmeng Li, Mei Zhang, Mingxue Di, Yifei Chen, Lin Wang, Xiaoling Liu, Xiaoqing Cao
Publikováno v:
Journal of molecular medicine (Berlin, Germany). 94(4)
Numerous clinical studies have highlighted the pivotal role Dickkopf (DKK) 1 plays in atherosclerosis, but the underlying mechanisms remain unknown. The present study was designed to explore the contribution of DKK1 to the development of atherosclero
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8fe7d4647a31392ff73357de6b5a10c
https://pubmed.ncbi.nlm.nih.gov/26607269
https://pubmed.ncbi.nlm.nih.gov/26607269